Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-24
2006-01-24
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S080000, C546S084000, C546S089000, C546S070000, C546S062000, C514S285000, C514S292000
Reexamination Certificate
active
06989388
ABSTRACT:
The present invention relates to compounds for the inhibition of poly(ADP-ribose) polymerase (PARP). In some embodiments, the compounds have the Formula:wherein the constituent variables are as defined herein. The invention further provides methods for the use of the compounds disclosed herein.
REFERENCES:
patent: 4113731 (1978-09-01), Winters et al.
patent: 4263304 (1981-04-01), Ishizumi et al.
patent: WO 99/11645 (1999-11-01), None
patent: WO 99/59975 (1999-11-01), None
Compound having RN 74796-97-7.
S. Kano et al., “A facile synthesis of 4-phenylcarbostyrils and 4-phenylisocarbostyril involving photocyclization of . . . ”, (1979), Heterocycles, 12(4), pp. 489-492.
Moroni Flavio
Pellicciari Roberto
Aulakh Charanjit S.
Moroni Flavio
O'Connor Cozen
Pellicciari Roberto
Straher Michael P.
LandOfFree
Thieno[2,3-c]iosquinolines for use as inhibitors of PARP does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thieno[2,3-c]iosquinolines for use as inhibitors of PARP, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thieno[2,3-c]iosquinolines for use as inhibitors of PARP will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3532560